Top Industry Leaders in the Pericarditis Market
Latest Pericarditis Companies Update:
R-Pharm International LLC announces positive Phase IIb results for CardiolRx: This investigational new drug for recurrent pericarditis demonstrates potential for long-term disease control and reduced risk of recurrence.
Cardiol Therapeutics acquires PerImmune to advance development of CardiolRx: This acquisition strengthens CardiolRx's clinical development program and expands its focus on treating recurrent pericarditis.
Abbott Laboratories partners with Inovio Pharmaceuticals to develop DNA vaccine for pericarditis: This collaboration aims to prevent pericarditis associated with viral infections or autoimmune diseases.
List of Pericarditis Key companies in the market
- Pfizer Inc.
- AstraZeneca Plc
- Novartis International AG
- Allergan plc.
- and Merck & Co., Inc.
- Bayer AG
- Reckitt Benckiser Group Plc.
- PerkinElmer, Inc.
- FUJIFILM Holdings Corporation
- Sanofi
- Johnson & Johnson Services